封面
市场调查报告书
商品编码
1423558

到 2030 年经皮毒理学测试市场预测:按类型、测试方法、测试类型、最终用户和地区进行的全球分析

Dermal Toxicity Testing Market Forecasts to 2030 - Global Analysis By Type (Product, Services and Other Types), Testing Method (In-vitro Testing, In-silico Modeling and In-vivo testing), Test Type, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据,2023 年全球经皮毒性​​测试市场规模为 23.2 亿美元,预计到 2030 年将达到 46 亿美元,预测期内复合年增长率为 10.3%。

经皮毒性测试是一种科学方法,用于评估化学物质与皮肤接触时的潜在有害影响。此类测试对于评估各种产品(包括化妆品、药品和工业化学品)的安全性至关重要。皮肤毒性测试评估各种参数,包括皮肤外观、红斑(发红)、水肿(肿胀)和其他刺激征兆。

根据癌症研究所统计,正在开发的活性药物数量增加了90%以上,2019年达到3,876种。目前正在考虑进行长期囓齿动物致癌性研究来评估该药物对人类的致癌性。

增加研发活动

研发活动的增加证实了开发新产品和配方对于将创新和安全的产品推向市场的重要角色。全面的经皮毒性研究对于评估这些进展的安全性至关重要。此外,满足不断变化的监管标准、保护公众健康以及向消费者灌输对新开发产品安全性的信心的需求正在推动对经皮毒性测试服务的需求。

高成本

经皮毒性测试需要专门的设施和设备才能获得准确可靠的结果。维护此类设施、取得和维护测试设备以及僱用技术人员的成本可能很高。此外,需要测试的物质的复杂性和多样性也增加了成本。此外,随着监管要求的发展,可能需要额外的测试和方法更新,导致合规成本增加,从而阻碍市场扩张。

消费者意识不断增强

人们对皮肤健康和安全的认识不断提高,促使消费者仔细检查产品标籤,并要求製造商提供透明度。消费者越来越意识到接触个人保健产品、化妆品和药品中某些化学物质所带来的潜在风险。此外,这种对安全的重视符合更广泛的消费者对健康和环境永续性优先考虑的产品趋势,这正在推动该市场的规模。

有限的标准化

缺乏标准化的通讯协定和指南给进行准确的风险评估和解释不同实验室和测试的测试结果带来了挑战。建立一致的标准来确定经皮接触物质的安全性也很困难。此外,缺乏协调导致监管机构和行业相关人员效率低下并增加成本,阻碍了市场扩张。

COVID-19 的影响

COVID-19 的爆发对经皮毒性测试市场产生了一些负面影响。经皮毒性测试市场高度依赖製药、化妆品和化学品行业,这些行业在大流行期间都受到了干扰。实验室关闭、设施准入限制和劳动力流动限制阻碍了经皮毒性测试的顺利进行,影响了产品核准和推出时间表。此外,景气衰退导致一些公司重新考虑对非必要测试服务的投资,影响了整体市场的成长。

In Silico模拟领域预计将在预测期内成为最大的领域

In Silico模拟领域预计占据最大份额,因为它旨在透过模拟分子间相互作用、吸收率以及对皮肤的潜在不利影响来准确预测经皮毒性。这些模型有助于减少动物测试,并且符合伦理考量和监管努力,以尽量减少在测试程序中使用动物。此外,机器学习和人工智慧等技术进步正在提高In Silico模型的准确性和可靠性,使其成为毒性评估的宝贵工具,并推动该领域的成长。

预计皮肤腐蚀测试产业在预测期内复合年增长率最高

预计皮肤腐蚀测试领域在预测期内复合年增长率最高。皮肤腐蚀测试是指对皮肤的严重损害,通常以皮肤组织破坏导致化学烧伤为特征。这些测试通常涉及涂布实验动物或试管内模型的皮肤,并进行观察以确定皮肤损伤的程度。此外,结果还可以帮助将物质分类为腐蚀性或非腐蚀性,为产品安全评估提供重要资料,并指南监管决策和安全评估。

比最大的地区

由于受到工业成长、不断变化的监管环境和产品安全意识不断增强等因素影响的动态市场形势,亚太地区在预测期内占据了最大份额。该地区包括中国、日本、印度和韩国等多元化经济体,透过严格的毒性测试通讯协定来帮助确保产品安全。此外,消费者对个人保健产品和药品的认识不断提高,进一步推动了该地区对全面经皮毒性测试的需求。

复合年增长率最高的地区:

由于欧洲对消费者安全的重视以及向试管内和In Silico模型等替代方法的重大转变,预计欧洲在预测期内将经历最高的复合年增长率。 Charles River Laboratories International、MatTek Corporation、Intertek Group 和 GE Healthcare 等主要企业正在为经皮毒性评估的准确性和效率做出贡献。此外,美国环保署 (EPA) 和食品药物管理局(FDA) 等机构制定的严格监管标准强调了全面毒性测试的重要性,从而推动了该地区的发展。

免费客製化服务:

订阅此报告的客户可以存取以下免费自订选项之一:

  • 公司简介
    • 其他市场参与者的综合分析(最多 3 家公司)
    • 主要企业SWOT分析(最多3家企业)
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率(註:基于可行性检查)
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病(COVID-19)的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球经皮毒理学测试市场:按类型

  • 产品
  • 服务
    • 内部服务
    • 外包服务
  • 其他类型

第六章全球经皮毒性​​测试市场:依测试方法

  • 体外测试
  • 电脑模拟
  • 体内测试

第七章全球经皮毒理学测试市场:依测试类型

  • 光毒性试验
  • 皮肤刺激测试
  • 皮肤致敏试验
  • 皮肤腐蚀试验
  • 其他考试类型

第八章全球经皮毒理学测试市场:依最终用户分类

  • 化妆品及个人保健产品产业
  • 化学工业
  • 医疗保健产业
  • 其他最终用户

第九章全球经皮毒理学测试市场:按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • SGS SA
  • Bio-Rad Laboratories Inc.
  • Charles River Laboratories International, Inc.
  • Catalent, Inc.
  • Eurofins Scientific Inc
  • Thermo Fisher Scientific, Inc.
  • Covance, Inc
  • GE Healthcare
  • Qiagen NV
  • Merck KgaA
  • Intertek Group
  • MatTek Corporation
  • Evotec
Product Code: SMRC24792

According to Stratistics MRC, the Global Dermal Toxicity Testing Market is accounted for $2.32 billion in 2023 and is expected to reach $4.60 billion by 2030 growing at a CAGR of 10.3% during the forecast period. Dermal toxicity testing is a scientific method employed to assess the potential harmful effects of chemical substances when they come into contact with the skin. This type of testing is crucial for evaluating the safety of various products, including cosmetics, pharmaceuticals, and industrial chemicals. Various parameters are assessed during dermal toxicity testing, such as skin appearance, erythema (redness), edema (swelling), and other signs of irritation.

According to the Cancer Research Institute, the number of active drugs in development grew by more than 90%, to 3,876 in 2019. Long-term rodent carcinogenicity studies for assessing the carcinogenic potential of drugs in humans are currently being examined.

Market Dynamics:

Driver:

Increasing research and development activities

The growth in R&D activities underscores the pivotal role of the development of new products and formulations to introduce innovative and safe products to the market. Comprehensive dermal toxicity testing becomes imperative to assess the safety profile of these advancements. Further, by the need to align with evolving regulatory standards, safeguard public health, and instill consumer confidence in the safety of newly developed products, the demand for dermal toxicity testing services is propelled.

Restraint:

High cost

Dermal toxicity testing requires specialized facilities and equipment to ensure accurate and reliable results. The costs of maintaining such facilities, acquiring and maintaining testing equipment, and employing skilled personnel can be significant. The complexity and diversity of substances that require testing further contribute to the costs. Furthermore, as regulatory requirements evolve, additional tests or updated methodologies may be necessary, leading to increased costs for compliance, which is hampering this market expansion.

Opportunity:

Rising consumer awareness

Rising awareness regarding skin health and safety prompts consumers to scrutinize product labels and demand transparency from manufacturers. Consumers are becoming more conscious of the potential risks associated with exposure to certain chemicals present in personal care products, cosmetics, and pharmaceuticals. Additionally, this emphasis on safety aligns with the broader trend of consumers seeking products that prioritize health and environmental sustainability, which are driving this market size.

Threat:

Limited standardization

The absence of standardized protocols and guidelines made it challenging to make accurate risk assessments and interpret test results obtained from different laboratories or studies. It also made it difficult to establish consistent criteria for determining the safety of substances in relation to dermal exposure. Moreover, the lack of harmonization resulted in inefficiencies and increased costs for both regulators and industry stakeholders, which are hindering this market expansion.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the dermal toxicity testing market. The dermal toxicity testing market relies heavily on the pharmaceutical, cosmetic, and chemical sectors, all of which experienced disruptions during the pandemic. Laboratory closures, restricted access to facilities, and limitations on workforce mobility impeded the smooth conduct of dermal toxicity tests, affecting timelines for product approvals and introductions. Furthermore, the economic downturn has prompted some businesses to reconsider their investments in non-essential testing services, affecting overall market growth.

The in-silico modeling segment is expected to be the largest during the forecast period

The in-silico modeling segment is estimated to hold the largest share, due to they aim to provide accurate predictions of dermal toxicity by simulating molecular interactions, absorption rates, and potential adverse effects on the skin. These models contribute to the reduction of animal testing, aligning with ethical considerations and regulatory efforts to minimize animal use in testing procedures. In addition, advancements in technology, such as machine learning and artificial intelligence, enhance the accuracy and reliability of in-silico models, making them valuable tools in toxicology assessments which are driving this segment's growth.

The skin corrosion tests segment is expected to have the highest CAGR during the forecast period

The skin corrosion tests segment is anticipated to have highest CAGR during the forecast period. It refers to severe damage to the skin, often characterized by the destruction of skin tissue, leading to chemical burns. These tests typically involve the application of the test substance to the skin of experimental animals or in vitro models, and observations are made to determine the extent of skin damage. Furthermore, the results help classify substances as corrosive or non-corrosive, guiding regulatory decisions and safety assessments by providing essential data for product safety assessments, which is boosting this segment expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to a dynamic landscape influenced by factors such as industrial growth, regulatory developments, and increasing awareness of product safety. The region encompasses diverse economies, including China, Japan, India, South Korea, and others, contributing to ensuring the safety of products through robust toxicity testing protocols. Moreover, increased awareness among consumers regarding personal care and pharmaceutical products further propels the demand for comprehensive dermal toxicity testing in this region.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a strong focus on consumer safety and cutting-edge testing methodologies, with a notable shift towards alternative methods such as in vitro and in silico models. Key players such as Charles River Laboratories International, MatTek Corporation, Intertek Group, and GE Healthcare contribute to the accuracy and efficiency of dermal toxicity assessments. Further, stringent regulatory standards set by agencies like the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) emphasize the importance of comprehensive toxicity testing, thereby driving this region.

Key players in the market

Some of the key players in the Dermal Toxicity Testing Market include SGS S.A, Bio-Rad Laboratories Inc., Charles River Laboratories International, Inc., Catalent, Inc., Eurofins Scientific Inc, Thermo Fisher Scientific, Inc., Covance, Inc , GE Healthcare, Qiagen N.V., Merck KgaA, Intertek Group, MatTek Corporation and Evotec.

Key Developments:

In December 2023, GE HealthCare and Nantworks AirStrip announced an agreement to Commercialize Integrated Patient Monitoring and Cardiac Data Visualization for Healthcare Systems.

In December 2023, SGS is pleased to announce the signing of an agreement to divest its crop science operations in 14 countries to Eurofins Scientific.

In November 2023, GE HealthCare (Nasdaq: GEHC) and Masimo announced a joint agreement to integrate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's Portrait Mobile wireless and wearable patient monitoring solution.

In October 2023, SGS is pleased to have signed an agreement to divest its US powertrain testing operations as part of its strategic portfolio evolution to Columbia River Partners, a private equity firm focused on the industrials, business services and IT services sectors.

Types Covered:

  • Product
  • Services
  • Other Types

Testing Methods Covered:

  • In-vitro Testing
  • In-silico Modeling
  • In-vivo Testing

Test Types Covered:

  • Phototoxicity Tests
  • Skin Irritation Tests
  • Skin Sensitization Tests
  • Skin Corrosion Tests
  • Other Test Types

End Users Covered:

  • Cosmetics and Personal Care Products Industry
  • Chemical Industry
  • Healthcare Industry
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Dermal Toxicity Testing Market, By Type

  • 5.1 Introduction
  • 5.2 Product
  • 5.3 Services
    • 5.3.1 Inhouse Services
    • 5.3.2 Outsource Services
  • 5.4 Other Types

6 Global Dermal Toxicity Testing Market, By Testing Method

  • 6.1 Introduction
  • 6.2 In-vitro Testing
  • 6.3 In-silico Modeling
  • 6.4 In-vivo testing

7 Global Dermal Toxicity Testing Market, By Test Type

  • 7.1 Introduction
  • 7.2 Phototoxicity Tests
  • 7.3 Skin Irritation Tests
  • 7.4 Skin Sensitization Tests
  • 7.5 Skin Corrosion Tests
  • 7.6 Other Test Types

8 Global Dermal Toxicity Testing Market, By End User

  • 8.1 Introduction
  • 8.2 Cosmetics and Personal Care Products Industry
  • 8.3 Chemical Industry
  • 8.4 Healthcare Industry
  • 8.5 Other End Users

9 Global Dermal Toxicity Testing Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 SGS S.A
  • 11.2 Bio-Rad Laboratories Inc.
  • 11.3 Charles River Laboratories International, Inc.
  • 11.4 Catalent, Inc.
  • 11.5 Eurofins Scientific Inc
  • 11.6 Thermo Fisher Scientific, Inc.
  • 11.7 Covance, Inc
  • 11.8 GE Healthcare
  • 11.9 Qiagen N.V.
  • 11.10 Merck KgaA
  • 11.11 Intertek Group
  • 11.12 MatTek Corporation
  • 11.13 Evotec

List of Tables

  • Table 1 Global Dermal Toxicity Testing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 4 Global Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
  • Table 5 Global Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
  • Table 6 Global Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
  • Table 7 Global Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
  • Table 9 Global Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 10 Global Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
  • Table 11 Global Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
  • Table 12 Global Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 13 Global Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
  • Table 14 Global Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
  • Table 15 Global Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
  • Table 16 Global Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
  • Table 17 Global Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 18 Global Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
  • Table 20 Global Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
  • Table 21 Global Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
  • Table 22 Global Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
  • Table 25 North America Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 26 North America Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
  • Table 27 North America Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
  • Table 28 North America Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
  • Table 29 North America Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 30 North America Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
  • Table 31 North America Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 32 North America Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
  • Table 33 North America Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
  • Table 34 North America Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 35 North America Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
  • Table 36 North America Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
  • Table 37 North America Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
  • Table 38 North America Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
  • Table 39 North America Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 40 North America Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 North America Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
  • Table 42 North America Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
  • Table 43 North America Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
  • Table 44 North America Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
  • Table 47 Europe Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 48 Europe Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
  • Table 49 Europe Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
  • Table 50 Europe Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
  • Table 51 Europe Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 52 Europe Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
  • Table 53 Europe Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 54 Europe Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
  • Table 55 Europe Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
  • Table 56 Europe Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 57 Europe Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
  • Table 58 Europe Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
  • Table 59 Europe Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
  • Table 60 Europe Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
  • Table 61 Europe Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 62 Europe Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 63 Europe Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
  • Table 64 Europe Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
  • Table 65 Europe Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
  • Table 66 Europe Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 Asia Pacific Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
  • Table 69 Asia Pacific Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 70 Asia Pacific Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
  • Table 71 Asia Pacific Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
  • Table 72 Asia Pacific Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
  • Table 73 Asia Pacific Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 74 Asia Pacific Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
  • Table 75 Asia Pacific Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 76 Asia Pacific Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
  • Table 77 Asia Pacific Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
  • Table 78 Asia Pacific Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 79 Asia Pacific Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
  • Table 80 Asia Pacific Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
  • Table 81 Asia Pacific Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
  • Table 82 Asia Pacific Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
  • Table 83 Asia Pacific Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 84 Asia Pacific Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 85 Asia Pacific Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
  • Table 86 Asia Pacific Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
  • Table 87 Asia Pacific Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
  • Table 88 Asia Pacific Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 South America Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
  • Table 91 South America Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 92 South America Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
  • Table 93 South America Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
  • Table 94 South America Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
  • Table 95 South America Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 96 South America Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
  • Table 97 South America Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 98 South America Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
  • Table 99 South America Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
  • Table 100 South America Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 101 South America Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
  • Table 102 South America Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
  • Table 103 South America Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
  • Table 104 South America Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
  • Table 105 South America Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 106 South America Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 107 South America Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
  • Table 108 South America Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
  • Table 109 South America Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
  • Table 110 South America Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • 111 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • 112 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Type (2021-2030) ($MN)
  • 113 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • 114 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Services (2021-2030) ($MN)
  • 115 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Inhouse Services (2021-2030) ($MN)
  • 116 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Outsource Services (2021-2030) ($MN)
  • 117 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Other Types (2021-2030) ($MN)
  • 118 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Testing Method (2021-2030) ($MN)
  • 119 Middle East & Africa Dermal Toxicity Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • 120 Middle East & Africa Dermal Toxicity Testing Market Outlook, By In-silico Modeling (2021-2030) ($MN)
  • 121 Middle East & Africa Dermal Toxicity Testing Market Outlook, By In-vivo testing (2021-2030) ($MN)
  • 122 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • 123 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Phototoxicity Tests (2021-2030) ($MN)
  • 124 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Skin Irritation Tests (2021-2030) ($MN)
  • 125 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Skin Sensitization Tests (2021-2030) ($MN)
  • 126 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Skin Corrosion Tests (2021-2030) ($MN)
  • 127 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • 128 Middle East & Africa Dermal Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • 129 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Cosmetics and Personal Care Products Industry (2021-2030) ($MN)
  • 130 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Chemical Industry (2021-2030) ($MN)
  • 131 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Healthcare Industry (2021-2030) ($MN)
  • 132 Middle East & Africa Dermal Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)